| Role |
Name |
Disclosure |
Details |
| Author | Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Associate Program Director, Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University | Nothing to disclose | Details | | Coauthor | Niranjan N Singh, MD, DNB, Fellow in Neurophysiology, Department of Neurology, St Louis University School of Medicine | Nothing to disclose | Details | | Medical Editor | Daniel H Jacobs, MD, Associate Professor of Neurology, University of Central Florida College of Medicine; Director, Multiple Sclerosis Care Center; Director of Stroke Services, Orlando Regional Medical Center; Clinical Associate Professor, Department of Neurology, University of Florida | Teva Pharmaceutical Biogen Idex Serono EMD Pfizer Berlex | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Glenn Lopate, MD, Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Chief of Neurology, St Louis ConnectCare, Consulting Staff, Barnes Jewish Hospital | Nothing to disclose | Details | | CME Editor | Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
|